Strengthens Pays $700M to Strengthen Oncology Portfolio with ISB 2001

Why did Nvidia resume AI chip sales to China? How are Trump's tariffs impacting US inflation? What caused JPMorgan’s profit to fall despite beat? Why are crypto bills stalling in the House? How will Apple’s rare-earth deal affect supply chains? What’s behind Tesla’s North American sales leadership exit? How did BlackRock’s big client redemption affect shares?

Strengthens Pays $700M to Strengthen Oncology Portfolio with ISB 2001

finance.yahoo.com/news/abbvie-abbv-strengthens-pays-700m-131029324.html

In This Article:
AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs’ top healthcare stock picks. On July 10, the stock jumped 3.4% on the confirmation of an exclusive licensing deal with IGI Therapeutics. The agreement is for lead asset ISB 2001, which targets oncology and autoimmune…

This story appeared on finance.yahoo.com, 2025-07-15 13:10:29.